Literature DB >> 2860516

Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.

T R Navin, K D Miller, R F Satriale, H O Lobel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2860516     DOI： 10.1016/s0140-6736(85)92819-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Fansidar--a treatment for AIDS-related pneumocystis?

Authors:  P M Bath; D A Lillicrap; M Winter
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

Review 2.  Therapy and prophylaxis of systemic protozoan infections.

Authors:  W C Van Voorhis
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 3.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

4.  Productivity Tracking: A Survey of Critical Care Pharmacist Practices and Satisfaction.

Authors:  Christy Cecil Forehand; Kathryn Fitton; Kelli Keats; Aaron Chase; Susan E Smith; Andrea Sikora Newsome
Journal:  Hosp Pharm       Date:  2021-06-16

5.  Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo.

Authors:  S F Queener; M S Bartlett; J D Richardson; M M Durkin; M A Jay; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

6.  Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.

Authors:  S Köppen; T Grünewald; G Jautzke; J Gottschalk; H D Pohle; B Ruf
Journal:  Clin Investig       Date:  1992-06

7.  Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.

Authors:  B Ruf; D Schürmann; F Bergmann; W Schüler-Maué; T Grünewald; H J Gottschalk; H Witt; H D Pohle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.